Lv2
140 积分 2022-02-15 加入
肿瘤电场治疗联合免疫疗法治疗胶质母细胞瘤的效果分析
22天前
已完结
Toripalimab en association avec cisplatine et gemcitabine pour le traitement des carcinomes indifférenciés du nasopharynx récidivants ou métastatique (UCNT RM) en première ligne
1个月前
已关闭
Efficacy and safety of autologous CIK cell therapy plus Toripalimab with or without chemotherapy in advanced NSCLC: A phase II study
1个月前
已完结
The place of JAK inhibitors in systemic juvenile idiopathic arthritis with lung disease (SJIA-LD): French experience
1个月前
已完结
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system
1个月前
已完结
An Updated Comprehensive Pharmacovigilance Study of Drug‐Induced Thrombocytopenia Based on FDA Adverse Event Reporting System Data
1个月前
已完结
Bilateral, sequential orbital inflammatory syndrome associated with ruxolitinib
1个月前
已完结
Adverse event of ruxolitinib cream: a real-world analysis based on FDA adverse event reporting system from 2021 to 2024
1个月前
已完结
Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial
2个月前
已完结
Extended survival of a patient with gastrointestinal multiple malignancies managed with anti-PD-1 immunotherapy: a case report
2个月前
已完结
皖公网安备34019202002308
